<< Read Full Article

Wyeth Cancer Drug Cleared

Stock quotes in this article: WYE , PFE , ONXX  

The Food and Drug Administration has approved Wyeth's (WYE Quote) Torisel for treating a type of advanced kidney cancer.

Torisel is the third drug approved by the FDA for renal cell carcinoma in the last 18 months. The agency endorsed Nexavar from Onyx Pharmaceuticals(ONXX Quote) and Bayer(BAY Quote) in December 2005, and it approved Pfizer's(PFE Quote) Sutent in January 2006.

The Wyeth drug was cleared based on clinical trials showing it prolonged patients' survival. The median overall survival was 10.9 months for patients on Torisel vs. 7.3 months for those treated with interferon. The comparison was statistically significant. ...

<< Read Full Article

Recent Comments

Loading .....




Dow Jones S&P 500 NASDAQ 10-Year Note
10,344.84 1,095.63 2,144.60 32.01
Oil *
78.55
UP
34.92
UP
4.14
UP
6.16
DOWN
0.30
10 Yr
3.20%
SPDR Gold
115.65
+0.34%
+0.38%
+0.29%
-0.93%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services